392 material Form 8-K filings that 341 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Trustmark reported second quarter 2024 net income of $73.8 million, or $1.20 per diluted share, up from $41.5 million and $0.68 in the first quarter. The result was driven by a $171.2 million after-tax gain on the sale of Fisher Brown Bottrell Insurance, which is reported in discontinued operations, while the loss from continuing operations was $100.6 million after a $182.8 million pre-tax loss on securities restructuring. Excluding these non-routine items, adjusted continuing operations net income was $40.5 million, or $0.66 per diluted share.
Net income of $73.8 million, or $1.20 per diluted share, versus $41.5 million, or $0.68 per diluted share, in the first quarter of 2024
Loss from continuing operations of $100.6 million, including a $182.8 million pre-tax loss on the securities portfolio restructuring
Adjusted continuing operations net income of $40.5 million, or $0.66 per diluted share
Board declared a quarterly cash dividend of $0.23 per share, payable September 15, 2024
On July 21, 2024, Dover entered into an agreement to sell its Environmental Solutions Group businesses to Terex Corporation for $2.0 billion in cash, subject to customary adjustments. Closing depends on customary conditions, including expiration of the Hart-Scott-Rodino waiting period, and either party may terminate if the deal is not completed by April 21, 2025. The filing does not state the financial effect of the sale on Dover's earnings or the use of proceeds.
Buyer: Terex Corporation; price: $2.0 billion in cash, subject to customary transaction adjustments
Agreement signed July 21, 2024; either party may terminate if the deal is not consummated by April 21, 2025
Closing requires the expiration or termination of the Hart-Scott-Rodino waiting period and no governmental order blocking the deal
Full agreement to be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2024
Weatherford reported second-quarter 2024 revenue of $1.405 billion, up 10% from a year earlier, with net income of $125 million and diluted earnings of $1.66 per share, compared with $1.12 a year earlier. The company also declared its first quarterly dividend of $0.25 per share, authorized a $500 million share repurchase program running through June 2027, and appointed Steven Beringhause to its board. Management reaffirmed expectations for adjusted free cash flow of over $500 million for the full year.
Revenue of $1,405 million, up 10% year over year and 3.5% sequentially; diluted EPS of $1.66 versus $1.12 in Q2 2023
Adjusted EBITDA of $365 million, a 26.0% margin; adjusted free cash flow of $96 million
Quarterly dividend of $0.25 per share payable September 12, 2024, to holders of record August 13, 2024
Steven Beringhause appointed to the board, increasing its size to six directors
EastGroup reported second-quarter 2024 diluted EPS of $1.14, up from $0.97 a year earlier, and FFO of $2.09 per share, up 9.4%. The company also revised its 2024 FFO guidance to $8.28-$8.38 per share from $8.17-$8.37 in April, a higher range for shareholders.
Q2 2024 diluted EPS was $1.14 versus $0.97 in Q2 2023; FFO excluding gains was $2.05 per share, up 8.5%
Same PNOI excluding lease termination income rose 5.3% on both straight-line and cash bases for the quarter
2024 FFO per share guidance revised to $8.28-$8.38; 2024 EPS guidance set at $4.63-$4.73
Operating portfolio was 97.4% leased as of June 30, 2024, with average occupancy of 97.0% for the quarter versus 98.1% a year earlier
Agree Realty reported second quarter 2024 results on July 23, 2024, with net income per share up 25.6% to $0.52 and AFFO per share up 6.4% to $1.04. The company raised its full-year 2024 AFFO per share guidance to $4.11 to $4.14 from $4.10 to $4.13 and lifted its acquisition volume outlook to approximately $700 million from approximately $600 million.
Q2 2024 net income per share rose 25.6% to $0.52; Core FFO per share rose 5.7% to $1.03
2024 AFFO per share guidance raised to $4.11 to $4.14 from $4.10 to $4.13
2024 acquisition volume guidance raised to approximately $700 million from approximately $600 million
Commitments received to expand the credit facility to $1.25 billion from $1.0 billion, with maturity extended to August 2029
Manhattan Associates reported second-quarter 2024 revenue of $265.3 million, up from $231.0 million a year earlier, and GAAP diluted earnings per share of $0.85 versus $0.63. The company also raised its full-year 2024 guidance, now projecting total revenue of $1,036 million to $1,044 million and GAAP diluted EPS of $3.08 to $3.16, with adjusted EPS of $4.22 to $4.30.
Q2 2024 total revenue was $265.3 million, compared with $231.0 million in Q2 2023.
Q2 2024 GAAP diluted EPS was $0.85, compared with $0.63; adjusted diluted EPS was $1.18, compared with $0.88.
2024 full-year guidance: total revenue $1,036 million to $1,044 million (12% growth) and GAAP EPS $3.08 to $3.16.
Cash flow from operations was $73.3 million in Q2 2024, compared with $40.6 million in Q2 2023; cash totaled $202.7 million at June 30, 2024.
Equity LifeStyle Properties reported second-quarter 2024 results on July 22, with net income per share of $0.42, up from $0.34, and normalized FFO per share of $0.66, up 2.9%. The accompanying release also increased the company's 2024 earnings guidance, with full-year normalized FFO per share now projected at $2.86 to $2.96. The filing also discloses a July 18 amendment extending the maturity of its $500 million line of credit to July 18, 2028, with other material terms, including interest rate terms, unchanged.
Q2 2024 net income per share was $0.42 versus $0.34 in Q2 2023; normalized FFO per share was $0.66 versus $0.64.
Full-year 2024 normalized FFO per share guidance is $2.86 to $2.96; third-quarter guidance is $0.69 to $0.75.
On July 18, 2024, the $500 million credit line maturity was extended to July 18, 2028, and the $300 million term loan gained an option to extend to April 16, 2027.
Quest Diagnostics reported second-quarter 2024 net revenues of $2.40 billion, up 2.5% from a year earlier, and raised its full-year 2024 revenue and adjusted diluted EPS guidance. Reported diluted EPS fell 1.0% to $2.03, while adjusted diluted EPS rose 2.2% to $2.35, so shareholders see higher sales and adjusted earnings alongside lower reported profit. The updated guidance excludes the pending LifeLabs acquisition.
Q2 2024 net revenues $2.40 billion, up 2.5%; net income attributable to Quest Diagnostics $229 million, down 2.4%
Q2 reported diluted EPS $2.03, down 1.0%; adjusted diluted EPS $2.35, up 2.2%
Full-year 2024 net revenues now expected at $9.50 billion to $9.58 billion, up from $9.40 billion to $9.48 billion
Full-year adjusted diluted EPS now expected at $8.80 to $9.00, up from $8.72 to $8.97; reported diluted EPS range $7.57 to $7.77, high end down from $7.82
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.